Target intelligence / Profile preview

Divalent cations (Calcium and Magnesium) (Ca2+/Mg2+)

Target
Ca2+/Mg2+
Molecular classification
Inorganic ions, Electrolytes
01

Overview

Divalent cations in dialysate and serum, primarily calcium (Ca2+) and magnesium (Mg2+), represent critical physiological parameters rather than a single therapeutic protein target. These ions are fundamental to biological life, participating in signal transduction, muscle contraction, bone mineralization, and acting as essential cofactors for over 300 enzymes (StatPearls, 2023). In the context of end-stage renal disease, the homeostatic regulation of these cations is severely impaired, necessitating external management via dialysis. The concentration of these ions in the dialysate is adjusted to facilitate the movement of cations into or out of the serum via diffusion across a semi-permeable membrane (KDIGO, 2017). Imbalances in these cations are directly linked to Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), which increases the risk of vascular calcification and cardiovascular mortality (PubMed, PMID: 25877701). Therapeutic strategies involve a combination of dialysate composition adjustments and pharmacological agents like calcimimetics. These drugs, such as cinacalcet, modulate the calcium-sensing receptor to maintain systemic mineral balance by regulating parathyroid hormone secretion (FDA, 2011). Monitoring these cations is a standard of care in nephrology to ensure patient safety and treatment efficacy.

Other names
Serum divalent cationsDialysate electrolytesCalcium and Magnesium ionsSerum calcium and magnesium
02

Mechanism of action

Regulation of serum concentrations via diffusive and convective transport across a semi-permeable membrane during dialysis, or through the activation of the calcium-sensing receptor (CaSR) to modulate parathyroid hormone levels and subsequent mineral mobilization.

03

Biological functions

Bone mineralizationSignal transductionMuscle contractionEnzyme cofactor activityNeuromuscular conduction
04

Disease associations

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)HypercalcemiaHypomagnesemiaVascular calcificationSecondary hyperparathyroidism
05

Safety considerations

Vascular calcificationAdynamic bone diseaseCardiac arrhythmiasNeuromuscular irritabilityHypocalcemia-induced QT prolongation
06

Interacting drugs

Cinacalcet

5 more in the full profile.

07

Biomarkers

Serum ionized calciumSerum total magnesiumIntact parathyroid hormone (iPTH)Fibroblast growth factor 23 (FGF23)

Beyond the preview

Go deeper on Divalent cations (Calcium and Magnesium) (Ca2+/Mg2+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Divalent cations (Calcium and Magnesium) (Ca2+/Mg2+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call